Solid Biosciences Inc. (SLDB) Covered Calls

You can sell covered calls on Solid Biosciences Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SLDB (prices last updated Fri 4:16 PM ET):

Solid Biosciences Inc. (SLDB) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.10 -0.13 10.02 10.60 675K - 0.4
Covered Calls For Solid Biosciences Inc. (SLDB)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 10 0.00 10.60 -5.7% -138.7%
Jun 21 10 1.20 9.40 6.4% 46.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to derive functional dystrophin protein expression in patients' muscles. Its portfolio also comprises Anti-LTBP4, a complementary disease modifying program that identifies and develops a monoclonal antibody intended to reduce fibrosis and inflammation by targeting and stabilizing the LTBP4 protein. In addition, the company engages in developing biomarkers and sensors; and Solid Suit program that includes the development of wearable assistive devices that focus on providing functional and therapeutic benefits. Solid Biosciences Inc. has strategic collaboration with Ultragenyx to develop and commercialize new gene therapies for Duchenne Muscular Dystrophy. Solid Biosciences Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.